Publications database

Displaying 1 - 5 of 5

Publication cover

New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic — an update from the EU Early Warning System

In this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early warning...

EU Drug Markets Report 2019

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. A more recent version of this publication is...

Highlights from the EU Drug Markets Report for policy and practice

This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice.

Publication's cover

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (α-PVP)

In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as α-pyrrolidinovalerophenone (α-PVP), through a joint assessment. The two organisations concluded that sufficient...

EWS report thumbnail

New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015)

This short report provides an update on new psychoactive substances (NPS) in Europe for 2014. It highlights recent developments, including the growth of the market over the past few years, as illustrated...